News: Bayer AG (BAYRY.PK)
111.30USD
19 Jun 2013
$-1.45 (-1.29%)
$112.75
$112.93
$113.19
$110.90
16,888
40,992
$113.19
$65.75
Mon, Jun 10 2013
Europe shares dip as Chinese data hits miners
PARIS, June 10 - European stocks ended slightly lower on Monday as China's unexpectedly weak imports data prompted investors to dump cyclical miners and pick up defensive companies such as Deutsche Telekom and Bayer .
Bayer say VEGF Trap-Eye shows promise as mCNV treatment
FRANKFURT, June 6 - Bayer said on Thursday its drug VEGF Trap-Eye had demonstrated to improve visual acuity in a late-stage trial on patients suffering from myopic choroidal neovascularization (mCNV).
Bayer says 96.4 pct of Conceptus shares tendered
FRANKFURT, June 5 - German drugmaker Bayer said on Wednesday it had been offered 96.4 percent of the shares in Conceptus, the U.S. maker of female sterilisation devices it agreed to buy in April.
UK cost agency recommends Bayer, Regeneron eye drug
LONDON, May 31 - Britain's healthcare cost watchdog NICE is recommending a new eye drug from Bayer and Regeneron, after a price discount was offered for its use on the state health service.
France says will back down over Bayer acne pill
PARIS - France's health regulator said on Thursday it would comply with the European Commission if it ruled that Bayer acne pill Diane 35 and its generic versions were safe to use in some cases.
UPDATE 1-France says will back down over Bayer acne pill
PARIS, May 30 - France's health regulator said on Thursday it would comply with the European Commission if it ruled that Bayer acne pill Diane 35 and its generic versions were safe to use in some cases.
RPT-France says will comply with EU over Diane 35 pill
PARIS, May 30 - France's health regulator said on Thursday it would comply with the European Commission if it ruled that Bayer acne pill Diane 35 and its generic versions were safe to use in some cases.
France says will comply with EU over Diane 35 pill
PARIS, May 30 - France's health regulator said on Thursday it would comply with the European Commission if it ruled that Bayer acne pill Diane 35 and its generic versions were safe to use in some cases.
Bayer says receives FTC nod for Conceptus buy
FRANKFURT, May 29 - Germany's Bayer said on Wednesday it had obtained antitrust clearance from the US Federal Trade Commission (FTC) for its planned $1.1 billion acquisition of U.S. contraceptive devices maker Conceptus .
German stocks - Factors to watch on May 21
FRANKFURT, May 21 - The DAX top-30 index looked set to open 0.2 percent lower on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0620 GMT.
- Gains In This Biotech Could Soon Become Infectious to Investors
- United Therapeutics Can't Stop Getting Rejected
- Go Slow With Pharma IPOs: KYTHERA, Intercept
- FDA Approval and a Trial Failure: Which Is More Important?
- Lipitor Loss? What's That?
- Inside Wall Street: Every January, It's a Four-Day Health Care Fest in San Francisco
Press Releases
- BNY Mellon and OTC Markets Group Announce New OTCM ADR Index, Powered by BNY Mellon DR Indices
- Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases
- REG - Official ListBayer AG - Cancellation - Bayer Akteingellschaft
- REG - Bayer AG - Intention to delist from the London Stock Exchange
- REG - Bayer AG - Research Update
- REG - Bayer AG - Half Yearly Report
- REG - Bayer AG - Dividend Declaration
- REG - Bayer AG - 1st Quarter Results
- REG - Bayer AG - Final Results
- REG - Bayer AG - Research Update

